BioBeats Announces New CEO Rob Brougham Strengthens Commercial Team to Drive Growth

This move highlights BioBeats’ intention to extend its leadership position and further accelerate its growth to become the platform for real-time consumer and corporate wellbeing monitoring and intervention, continuing to expand its reach and offering. In order to achieve these objectives, David and the Board identified the need to have an experienced commercial CEO to lead the next phase of the growth plan, and since the beginning of the year David has led the Board’s search for the right person.

Rob has a wealth of relevant experience gathered from 20 years’ in senior commercial, operational and technical roles working at both large, complex organisations and smaller, entrepreneurial environments. He has successfully grown end to end businesses within large corporate environments at BT, Virgin Media Business and Colt Telecommunications. Much of this expertise has been focused on managing fast growth, entrepreneurial business units – extremely relevant to BioBeats. In his previous role, he was CEO of the Telehealth and Telecare business for BT Global Services, responsible for the P&L and selling into the NHS and private sector. Before this, he held various Director positions at BT responsible for developing pioneering product marketing campaigns as well as partnerships and sales where he led the successful close of BT Wholesale’s largest ever deal at over £1billion.

Prior to this Rob was Director of Product at COLT Telecommunications, where he built and led an international product team and tripled international bandwidth sales in less than a year.

David Plans, Co-Founder of BioBeats, commented; “We are absolutely thrilled to welcome Rob on board to complement our extremely strong team of developers, AI and Machine Learning PhDs as we expand our commercial team and roll-out to corporate clients. Rob’s experience of direct selling, marketing, product, partnerships and high-volume operations will be invaluable in taking us to the next level.”

Rob Brougham, CEO of BioBeats, added, “BioBeats represents a significant opportunity and I am delighted to be joining a strong team and a Board of knowledgeable investors with a real passion for wellness and growth. I have been impressed by how BioBeats has led innovation in the market, and its ability to date to anticipate new opportunities, scientific approach and technology. I am looking forward to building on these successes and creating an exciting future ahead for us in the corporate wellness space.”

About BioBeats

BioBeats is a digital health and artificial intelligence business that creates corporate and personal wellness solutions. Its world-class team of scientists and designers includes renowned experts in AI, machine learning, wearables, cloud solutions and theoretical computer science.

Currently focused on stress and productivity, BioBeats provides insights into an individual’s health and wellbeing by tracking data from wearable and smartphone sensors. Biometric and psychometric feedback is combined with unique machine learning algorithms to deliver personalized stress and productivity management tools based on clinically proven coaching techniques.

BioBeats’ core solutions are based on many years of research, which demonstrates that biometric markers – including skin conductance and heart rate variability – are reliable indicators of stress. Combining these measures with insights into an individual’s daily lifestyle allows BioBeats to offer an unprecedented level of insight and support.

Following the launch of its consumer facing app Hear and Now (recently featured in Apple App Store’s Best New Apps, April 2016), the team provides tools to foster wellness at scale, with bespoke corporate versions in active deployment. The company’s corporate offering provides solutions to help employees privately control their own wellness through the use of wearables and data-driven coaching.

BioBeats has also established solutions in products including The Breathing Stone, a hand-held social therapeutic robot that helps people manage anxiety and pain in clinical conditions.

Press Contact
Name: Travis Street